BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kordzadeh-Kermani E, Khalili H, Karimzadeh I, Salehi M. Prevention Strategies to Minimize the Infection Risk Associated with Biologic and Targeted Immunomodulators. Infect Drug Resist 2020;13:513-32. [PMID: 32110062 DOI: 10.2147/IDR.S233137] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Yarahmadi P, Alirezaei M, Forouzannia SM, Naser Moghadasi A. The Outcome of COVID-19 in Patients with a History of Taking Rituximab: A Narrative Review. Iran J Med Sci 2021;46:411-9. [PMID: 34840381 DOI: 10.30476/IJMS.2021.88717.1946] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Zalona Fernandes HM, Mastrobuono G, Conceição EC, da Silva Dias RC, Alviano DS, Duarte RS. Coronavirus disease 2019 (COVID-19) treatment versus mycobacterial infections: Better safe than sorry? Infect Control Hosp Epidemiol 2021;:1-2. [PMID: 33736718 DOI: 10.1017/ice.2021.124] [Reference Citation Analysis]